Swahili
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Fatigue in Breast Cancer: A Behavioral Sleep Intervention

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
Kiungo kimehifadhiwa kwenye clipboard
HaliImekamilika
Wadhamini
University of Nebraska

Maneno muhimu

Kikemikali

1. This randomized clinical trial compares a four component behavioral sleep intervention group to an attention control healthy eating group
2. The behavioral sleep intervention is designed to reduce fatigue in women with stages I-IIIA breast cancer receiving anthracycline-based chemotherapy
3. The intervention uses an Individual Sleep Promotion Plan to promote daytime activity and nighttime sleep,and to decrease physchological and symptom distress
4. The healthy eating group receives equal time and attention and information on healthy eating
5. All participants receive a research nurse visit 2 days prior to each chemotherapy treatment, and 30, 60, 90 days after the last treatment, and one-year after the first treatment.
6. Adherence to the intervention is calculated at each time
7. Reliable and valid instruments are used, including wrist actigraphy

Maelezo

Higher fatigue levels are found in women with stage I, II or IIIA breast cancer receiving adjuvant chemotherapy (CT) who adopt patterns of daytime inactivity and nighttime restlessness and have more symptom and psychological distress. Interventions that improve sleep quality and reduce daytime fatigue in persons with insomnia may also benefit women receiving adjuvant CT. Using selected factors from Piper's Integrated Fatigue Model (IFM), a randomized, controlled clinical trial will compare women with breast cancer who receive a four component behavioral sleep intervention to women in the attentional control group during and after adjuvant CT. The intervention is designed to reduce fatigue in these women by promoting daytime activity, improving sleep quality and decreasing symptom and psychological distress. The aims of this study are to: 1) Compare the immediate (sleep/wake, activity/exercise, symptoms, psychological distress) and consequent (fatigue) outcomes of women who receive a four component behavioral sleep intervention (sleep hygiene counseling, relaxation therapy, sleep restriction and stimulus control) (n=110) with the outcomes in the healthy eating group (n=110) in women with stage I, II or IIIA breast cancer during 4 or 8 cycles of adjuvant chemotherapy, at 30, 60 and 90 days after their last treatment, and 1 year after their first treatment; 2) Determine the extent to which factors selected from the IFM influence fatigue intensity levels a) in the total sample at baseline and b) differentially influence fatigue intensity levels between groups 30 days after the last chemotherapy treatment and 1 year after the first treatment and 3) Evaluate the adherence to the refined behavioral sleep intervention and preferences for sleep hygiene and relaxation therapy techniques in the experimental group over time. Women will be randomized on the basis of good or poor sleeping history and intent to treat (4 versus 8 cycles of CT) to the intervention or attentional control group. Using the co-scientist model, the sleep intervention group will follow an Individual Sleep Promotion Plan negotiated with the investigator with regularly scheduled reinforcements and revisions. The healthy eating group will receive equal time and attention regarding general topics and nutrition. Established instruments include the Piper Fatigue Scale, Hospital Anxiety and Depression Scale, SF-36 Health Survey, Symptom Experience Scale, Daily Diary and Pittsburgh Sleep Quality Index. Objective measures include wrist actigraph, hemoglobin/ hematocrit, white blood count, T4 & TSH, and body mass index and a C - reactive protein at 1 year. Statistical analyses include RM-ANOVA, generalized estimation equation methodology and multiple regression analysis. Results may inform development of clinical guidelines for fatigue management during adjuvant CT.

Tarehe

Imethibitishwa Mwisho: 11/30/2007
Iliyowasilishwa Kwanza: 12/10/2007
Uandikishaji uliokadiriwa Uliwasilishwa: 12/11/2007
Iliyotumwa Kwanza: 12/12/2007
Sasisho la Mwisho Liliwasilishwa: 12/11/2007
Sasisho la Mwisho Lilichapishwa: 12/12/2007
Tarehe halisi ya kuanza kwa masomo: 03/31/2003
Tarehe ya Kukamilisha Utafiti: 05/31/2006

Hali au ugonjwa

Breast Cancer

Uingiliaji / matibabu

Behavioral: 1

Behavioral: 2

Awamu

Awamu 3

Vikundi vya Arm

MkonoUingiliaji / matibabu
Experimental: 1
Four component behavioral sleep intervention comprised of activity-rest, sleep-wake, phychological distress and symptom management. Four components of the Individual Sleep Promotion Plan are: stimulus control, sleep restruction, relaxation, and sleep hygiene.
Behavioral: 1
Four components, including activity-rest, sleep-wake, psychological distress, and symptom management. Sleep-wake component has four strategies: stimulus control, sleep restriction, relaxation, and sleep hygiene
Placebo Comparator: 2
Equal time and attention, information about healthy eating and general conversation
Behavioral: 2
Equal time and attention and information about healthy eating

Vigezo vya Kustahiki

Zama zinazostahiki Kujifunza 19 Years Kwa 19 Years
Jinsia Inastahiki KujifunzaAll
Hupokea Wajitolea wa AfyaNdio
Vigezo

Inclusion Criteria:

- Ages 19 and older

- Diagnosed for the first time with stage I-IIIA breast cancer

- Post-operative for breast cancer

- Scheduled to receive anthracycline-based adjuvant chemotherapy with our without taxane chemotherapy

- English speaking

- Karnofsky performance Scale score equal to or greater than 60

Exclusion Criteria:

- Comorbid diagnosis of chronic insomnia

- Sleep apnea or chronic fatigue syndrome

- Unstable congestive heart failure

- Chronic obstructive pulmonary disease

- Insulin-depenent diabetes

- Neruomuscular disease

- Abnormal thryoid function

- Depression, or

- Treatment with steriods

- Erratic sleep schedule due to working rotating shifts

Matokeo

Hatua za Matokeo ya Msingi

1. fatigue as measured by Piper Fatigue Scale [1 year]

Hatua za Matokeo ya Sekondari

1. activity-rest as measured by SF-36v2 and actigraphy [1 year]

2. sleep-wake as measured by Pittsburgh Sleep Quality Index and actigraphy [1 year]

3. pyschological mood as measured by Hospital Anxiety and Depression Scale [1 year]

4. symptom experience as measured by Symptom Experience Scale [1 year]

Jiunge na ukurasa
wetu wa facebook

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi

  • Inafanya kazi katika lugha 55
  • Uponyaji wa mitishamba unaungwa mkono na sayansi
  • Kutambua mimea kwa picha
  • Ramani ya GPS inayoshirikiana
  • Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
  • Tafuta mimea ya dawa na athari zao
  • Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu

Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa

Google Play badgeApp Store badge